Hudson Bay Capital Management’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Hudson Bay Capital Management’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-16	Closed	-$249K	–	178
2014 Q1	$249K	Buy	+16	New	+$274K	0.01%	166

Other funds holding CANF

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

Hudson Bay Capital Management's CANF Position: Q2 2014 in Review

Hudson Bay Capital Management sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q2 2014, closing a stake of 16 shares — an estimated $249K sold.

Hudson Bay Capital Management first reported a position in CANF in Q1 2014 and held it in 1 quarter. The position peaked at $249K in Q1 2014. 2 funds tracked by Wall St. Rank hold CANF as of Q2 2014.

Hudson Bay Capital Management reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q2 2014 after selling out during the quarter.
Hudson Bay Capital Management sold 16 Can-Fite BioPharma American Depositary Shares shares in Q2 2014, an estimated $249K.
Hudson Bay Capital Management first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2014 and held it in 1 quarter.
Hudson Bay Capital Management's Can-Fite BioPharma American Depositary Shares position peaked at $249K in Q1 2014.
2 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q2 2014.

Based on Hudson Bay Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.